
    
      The Primary Objectives of this study is collect the real clinical background of advanced
      colorectal cancer treatment situation of China. The Secondary Objectives is the mutation of
      K-ras , targeting therapy , use present situation of cetuximab and liver metastases treatment
      situation of colorectal cancer patients.
    
  